89 related articles for article (PubMed ID: 3509363)
1. Susceptibility of 89,517 gram-negative isolates to aztreonam and other antibiotics.
Lindsay G; Woods P
Chemioterapia; 1987 Jun; 6(2 Suppl):106. PubMed ID: 3509363
[No Abstract] [Full Text] [Related]
2. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Shibl AM; Ishag AH; Durgham SM
J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439
[No Abstract] [Full Text] [Related]
3. In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
Landinez R; Garcia M; Merino C
Chemioterapia; 1987 Jun; 6(2 Suppl):112-4. PubMed ID: 3509365
[No Abstract] [Full Text] [Related]
4. Aztreonam in the treatment of gram-negative meningitis in children.
Isani Z; Rehman N; Adil N; el Messidi M
Chemioterapia; 1987 Jun; 6(2 Suppl):428-30. PubMed ID: 3334590
[No Abstract] [Full Text] [Related]
5. [In vitro chemo-antibiotic sensitivity of gram-negative bacteria from various biological materials. Comparison between aztreonam and other agents].
Monaci E; Monaci R; Giacalone G; Meoni S
Minerva Med; 1987 May; 78(9):617-22. PubMed ID: 3587729
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E
Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity of aztreonam against gram-negative bacilli isolated in 1985.
Miyake Y; Yokoyama T; Nakano H; Kuwabara M; Yamakido M; Suginaka H
Hiroshima J Med Sci; 1988 Sep; 37(3):115-7. PubMed ID: 3248945
[No Abstract] [Full Text] [Related]
8. Aztreonam in the therapy of severe gram-negative infections.
Davies A; Stone J; Hassan A; Quarty P; Green T
Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
[No Abstract] [Full Text] [Related]
9. [Antibiotic sensitivity of gram-negative bacteria in intensive care units in Switzerland].
Wüst J; Auckenthaler R; Breer C; Frei R; Heinzer I; Kamm W
Schweiz Med Wochenschr; 1994 Oct; 124(39):1695-700. PubMed ID: 7939535
[TBL] [Abstract][Full Text] [Related]
10. Azthreonam: in vitro activity.
Gobernado M; Cantón E; Santos M
Microbiol Esp; 1983; 36(3-4):123-32. PubMed ID: 6687197
[No Abstract] [Full Text] [Related]
11. Aztreonam: preclinical studies.
Bonner DP; Tanaka SK; Schwind RA
N J Med; 1986 Jan; Spec No():20-5. PubMed ID: 3456495
[No Abstract] [Full Text] [Related]
12. In vitro studies with aztreonam, a new monobactam antibiotic.
Peddie BA
N Z Med J; 1986 Apr; 99(799):249. PubMed ID: 3458073
[No Abstract] [Full Text] [Related]
13. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of aztreonam--a new monocyclic beta-lactam antibiotic.
Friis H
Dan Med Bull; 1985 Jun; 32(3):196-8. PubMed ID: 4040456
[TBL] [Abstract][Full Text] [Related]
15. [Non-fermenting Gram-negative bacteria of human origin. II. In vitro sensitivity of 185 strains to 17 antibiotics and chemotherapeutic agents in clinical use].
Paredes L; Thompson L; del Canto E; Paredes L
Rev Latinoam Microbiol; 1986; 28(2):109-16. PubMed ID: 3797861
[No Abstract] [Full Text] [Related]
16. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
[TBL] [Abstract][Full Text] [Related]
17. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
Honderlick P; Gravisse J; Dardelle D; Cahen P
Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
[TBL] [Abstract][Full Text] [Related]
18. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007).
Patzer JA; Dzierzanowska D; Turner PJ
J Antimicrob Chemother; 2008 Aug; 62(2):369-75. PubMed ID: 18445575
[TBL] [Abstract][Full Text] [Related]
19. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
[TBL] [Abstract][Full Text] [Related]
20. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Thabaut A; Meyran M; Huerre M
Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
